Search results
Results from the WOW.Com Content Network
The stock of Puma SE (OTCPK:PUMSY, 30-year Financials) appears to be significantly overvalued, according to GuruFocus Value calculation.
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as PUMA SE (DB:PUM) with a market-capitalization of €5.82B, rarely draw their attention. Despite this ...
Puma has been a public company since 1986, listed on the Frankfurt Stock Exchange. French luxury group Kering (formerly known as PPR) holds 9.8%, Kering's largest shareholder Groupe Artemis owns 29% of the share capital. [47] Puma ranks as one of the top shoe brands with Adidas and Nike, [8] and employs more than 18,000 people worldwide. [5]
The MDAX is a stock index which lists German companies trading on ... The index is based on prices generated in the electronic ... PUMA SE: Sports equipment 3,67 ...
For premium support please call: 800-290-4726 more ways to reach us
He joined Puma in 1990, and in 1993 was appointed Chairman and CEO, becoming the youngest CEO in German history to head a public company at the age of 30. [4] He then led the worldwide restructuring of Puma, which was in financial difficulties at the time, and implemented a long-term development plan [6] [7] that saw Puma's share price gain around 4,000 percent [8] in 13 years, from €8.6 in ...
The S&P 500 is a stock market index maintained by S&P Dow Jones Indices. It comprises 503 common stocks which are issued by 500 large-cap companies traded on the American stock exchanges (including the 30 companies that compose the Dow Jones Industrial Average). The index includes about 80 percent of the American market by capitalization.
Puma Biotech (PBYI) betters loss estimates in Q3. However, its only marketed drug, Nerlynx, disappoints with low sequential growth and as a result, shares take a hit.